AI assistant
Sending…
NEOGENOMICS INC — Director's Dealing 2012
May 2, 2012
32227_dirs_2012-05-02_ec62e336-204d-4fb7-b8e3-4b45db3c0c4c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NGNM.OB)
CIK: 0001077183
Period of Report: 2012-05-02
Reporting Person: CARDOZA GEORGE (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-02 | Common Stock | P | 4000 | $1.66 | Acquired | 50337 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 20000 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock option (Right to Buy) | $1.55 | 2014-11-29 | Common Stock (0) | 150000 | Direct |
| Stock option (Right to Buy) | $1.46 | 2016-04-13 | Common Stock (0) | 100000 | Direct |
Footnotes
F1: The amount includes exempt purchases made under the Company's stock purchase plan.
F2: On November 30, 2009 Mr. Cardoza was granted an option to purchase 150,000 shares. The options were all time based and vest ratable over each of Mr. Cardoza's first four anniversaries with the Company.
F3: On April 14, 2011 Mr. Cardoza was granted an option to purchase 100,000 shares. These options vest ratably at the first four anniversary dates of the grant.
More from NEOGENOMICS INC
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24